Julie Metcalf

Julie Metcalf

Company: Fusion Pharmaceuticals

Job title: Senior Scientist


EGFRvIII-Targeted Alpha Therapy for Precision Cancer Cell Destruction in GBM 4:00 pm

What is targeted alpha therapy (TAT) and theranostics? Advantages of TAT for treatment of GBM Preclinical evaluation of an EGFRvIII-targeted alpha therapy in PDX models with varying degrees of BBB permeabilityRead more

day: Conference Day 2

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.